Another CMO mishap stings Cubist

Cubist Pharmaceuticals ($CBST) is recalling 100 lots of its banner antibiotic Cubicin after problems with a contract manufacturer, its third such issue in 12 months. The latest and largest recall follows one from August 2013 and another in April, each plagued by the discovery of glass particles in the injectable treatment and each blamed on a CMO. More